These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32980800)

  • 21. Affinity Tags for Protein Purification.
    Mishra V
    Curr Protein Pept Sci; 2020; 21(8):821-830. PubMed ID: 32504500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization with Human Papillomavirus 16 L1+E2 Chimeric Capsomers Elicits Cellular Immune Response and Antitumor Activity in a Mouse Model.
    López-Toledo G; Schädlich L; Alonso-Castro ÁJ; Monroy-García A; García-Rocha R; Guido MC; Gissmann L; García-Carrancá A
    Viral Immunol; 2016 Jun; 29(5):276-87. PubMed ID: 27058179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plant-based chimeric HPV-virus-like particles bearing amyloid-β epitopes elicit antibodies able to recognize amyloid plaques in APP-tg mouse and Alzheimer's disease brains.
    Gonzalez-Castro R; Acero Galindo G; García Salcedo Y; Uribe Campero L; Vazquez Perez V; Carrillo-Tripp M; Gevorkian G; Gomez Lim MA
    Inflammopharmacology; 2018 Jun; 26(3):817-827. PubMed ID: 29094307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens in Cervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine.
    Deschuyteneer M; Elouahabi A; Plainchamp D; Plisnier M; Soete D; Corazza Y; Lockman L; Giannini S; Deschamps M
    Hum Vaccin; 2010 May; 6(5):407-19. PubMed ID: 20953154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VLP production in Leishmania tarentolae: A novel expression system for purification and assembly of HPV16 L1.
    Bolhassani A; Shirbaghaee Z; Agi E; Davoudi N
    Protein Expr Purif; 2015 Dec; 116():7-11. PubMed ID: 26304732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In silico/In vivo analysis of high-risk papillomavirus L1 and L2 conserved sequences for development of cross-subtype prophylactic vaccine.
    Namvar A; Bolhassani A; Javadi G; Noormohammadi Z
    Sci Rep; 2019 Oct; 9(1):15225. PubMed ID: 31645650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of an Escherichia coli-derived human papillomavirus type 16 and 18 bivalent vaccine.
    Gu Y; Wei M; Wang D; Li Z; Xie M; Pan H; Wu T; Zhang J; Li S; Xia N
    Vaccine; 2017 Aug; 35(35 Pt B):4637-4645. PubMed ID: 28736197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promiscuity of host cell proteins in the purification of histidine tagged recombinant xylanase A by IMAC procedures: A case study with a Ni
    Yang Y; Mitri K; Zhang C; Boysen RI; Hearn MTW
    Protein Expr Purif; 2019 Oct; 162():51-61. PubMed ID: 31170454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimized production strategy of the major capsid protein HPV 16L1 non-assembly variant in E. coli.
    Roos N; Breiner B; Preuss L; Lilie H; Hipp K; Herrmann H; Horn T; Biener R; Iftner T; Simon C
    Protein Expr Purif; 2020 Nov; 175():105690. PubMed ID: 32681956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minor Capsid Protein L2 Polytope Induces Broad Protection against Oncogenic and Mucosal Human Papillomaviruses.
    Pouyanfard S; Spagnoli G; Bulli L; Balz K; Yang F; Odenwald C; Seitz H; Mariz FC; Bolchi A; Ottonello S; Müller M
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29212932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer.
    Baek JO; Seo JW; Kwon O; Park SM; Kim CH; Kim IH
    Enzyme Microb Technol; 2012 Mar; 50(3):173-80. PubMed ID: 22305172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression, purification, and renaturation of a recombinant peptide-based HIV vaccine in Escherichia coli.
    He W; Shu J; Zhang J; Liu Z; Xu J; Jin X; Wang X
    Can J Microbiol; 2017 Jun; 63(6):493-501. PubMed ID: 28177783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The production of human papillomavirus type 16 L1 vaccine product from Escherichia coli inclusion bodies.
    Lai WB; Middelberg AP
    Bioprocess Biosyst Eng; 2002 Jun; 25(2):121-8. PubMed ID: 14505012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of the protein oligomericity on final yield after affinity tag removal in purification of recombinant proteins.
    Kenig M; Peternel S; Gaberc-Porekar V; Menart V
    J Chromatogr A; 2006 Jan; 1101(1-2):293-306. PubMed ID: 16256128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced mucosal and systemic immune responses following intravaginal immunization with human papillomavirus 16 L1 virus-like particle vaccine in thermosensitive mucoadhesive delivery systems.
    Park JS; Oh YK; Kang MJ; Kim CK
    J Med Virol; 2003 Aug; 70(4):633-41. PubMed ID: 12794729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One-step chromatographic purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae.
    Kim HJ; Kim SY; Lim SJ; Kim JY; Lee SJ; Kim HJ
    Protein Expr Purif; 2010 Mar; 70(1):68-74. PubMed ID: 19686852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and Purification of Recombinant Proteins in Escherichia coli Tagged with the Metal-Binding Proteins SmbP and CusF3H.
    Gomez-Lugo JJ; Santos BD; Perez-Perez DA; Montfort-Gardeazabal JM; McEvoy MM; Zarate X
    Methods Mol Biol; 2021; 2178():329-344. PubMed ID: 33128759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of human papilloma virus L1 virus-like particles to dendritic cells is mediated through heparan sulfates and induces immune activation.
    de Witte L; Zoughlami Y; Aengeneyndt B; David G; van Kooyk Y; Gissmann L; Geijtenbeek TB
    Immunobiology; 2007; 212(9-10):679-91. PubMed ID: 18086370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay.
    Robbins HA; Waterboer T; Porras C; Kemp TJ; Pawlita M; Rodriguez AC; Wacholder S; Gonzalez P; Schiller JT; Lowy DR; Esser M; Matys K; Poncelet S; Herrero R; Hildesheim A; Pinto LA; Safaeian M
    Hum Vaccin Immunother; 2014; 10(10):2965-74. PubMed ID: 25483632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three-step chromatographic purification procedure for the production of a his-tag recombinant kinesin overexpressed in E. coli.
    Gibert S; Bakalara N; Santarelli X
    J Chromatogr B Biomed Sci Appl; 2000 Jan; 737(1-2):143-50. PubMed ID: 10681050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.